We announce that new shares have been issued through a third-party allotment to investors including Tokyu Agency Inc. for business expansion, support of R&D, and overseas expanion of the nematode cancer test “N-NOSE.”
On Thursday, March 16, "DAVOS 2023 DEBRIEFING" was held by the Consulate of Switzerland in Osaka.Our CMO/CGO, Shunsuke Mizushima, was invited as . . .
2023.03.20HIROTSU BIO SCIENCE releases a cancer screening for “Pet Dogs”. “N-NOSE Dogs” Website now available. －Pre-order available, special discounts ar . . .
2023.03.10Our CEO made a courtesy call on Minister Yasutoshi Nishimura.
2023.02.27